Exebacase - CISMeF

Preferred Label : Exebacase;

NCIt definition : A recombinant peptidoglycan hydrolase, with potential bacteriolytic activity against Staphylococcus aureus. Upon administration, exebacase targets a highly conserved and vital region of the bacterial cell wall of S. aureus and acts as a direct lytic agent. This results in bacteriolysis and biofilm eradication.;

UNII : 67F0M5CY5Y;

CAS number : 1404122-92-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1404122-92-4 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : CF 301; CF-301;

NCI Metathesaurus CUI : CL972156;

Details

Origin ID

C166908;

UMLS CUI

C5238170;

Automatic exact mappings (from CISMeF team)
- exebacase [MeSH Supplementary Concept]
- exebacase [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- exebacase [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients